Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Telo Genomics Corp V.TELO

Alternate Symbol(s):  TDSGF

Healthcare Industrials Biotechnology Conglomerates
Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of... see more

Recent & Breaking News (TSXV:TELO)

Telo Genomics Announces Full-Services Investor Relations Agreement with Adelaide Capital

Newsfile September 21, 2021

Telo Genomics (TSXV:TELO) participates in the 18th International Myeloma Society Workshop 2021

Brieanna McCutcheon  September 9, 2021

Telo Genomics Participates in the 18th International Myeloma Society Workshop 2021

Newsfile September 9, 2021

Telo Genomics Engages Clinical and Regulatory Affairs Veteran to Lead the Company's ISO 15189 Certification & CLIA Laboratory Accreditation Undertaking

Newsfile August 9, 2021

Telo Genomics (TSXV:TELO) completes final tranche of private placementTelo Genomics (TSXV:TELO) completes final tranche of private placement

Trevor Abes  July 5, 2021

Telo Genomics Completes Final Tranche of Oversubscribed Private Placement

Newsfile July 5, 2021

Telo Genomics (TSXV:TELO) completes first tranche of private placement

John Ballem  July 2, 2021

Telo Genomics Completes First Tranche of Oversubscribed Private Placement

Newsfile July 2, 2021

Telo Genomics (TSXV:TELO) announces private placement financing

John Ballem  June 18, 2021

Telo Genomics Announces Private Placement of Units

Newsfile June 18, 2021

3 World-Shaking Trends Investors Need To Watch This Year

Press Releases May 21, 2021

Telo Genomics Announces Co-Authored Publication of a Prospective 5-year Multiple Myeloma Study - Successfully Identifying High Risk versus Low Risk Smoldering Myeloma Patients

Newsfile April 29, 2021

Telo Genomics Announces AGM Voting Results and Provides Corporate Update

Newsfile March 24, 2021

Telo Genomics Retains Former Abbott & Siemens Veteran Gregg Mayer to Lead the Development of the Company's Industry Partnership Strategy

GlobeNewswire February 3, 2021

Telo Genomics Presents at ASH 2020 The Results of Hodgkin's Lymphoma Clinical Study

GlobeNewswire December 9, 2020

Telo Genomics Announces Study Results Showing That TeloView® Differentiates Between Stable Smoldering Multiple Myeloma Patients and Patients That Progressed to Active Multiple Myeloma

GlobeNewswire November 16, 2020

Telo Genomics Announces the Final Assignment of Patents on Hematological Cancers, Liquid Biopsy and Alzheimer's Disease

GlobeNewswire November 11, 2020

Telo Genomics Announces Warrant Exercise Agreement

GlobeNewswire October 21, 2020

Telo Genomics Announces that Positive Results of Smoldering Multiple Myeloma Study Selected for Online Publication Within ASH 2020 Proceedings

GlobeNewswire October 13, 2020

Telo Genomics Launches a Commercial Evaluation of Applied Spectral Imaging Automation (AI) with TELO Workflow

GlobeNewswire September 14, 2020